Fujiyama K - Search Results

1

Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones.

Abe Y, Ejima E, Fujiyama K, Kiriyama T, Ide A, Sera N, Tominaga T, Ashizawa K, Yokoyama N, Eguchi K. Abe Y, et al. Among authors: fujiyama k. Clin Endocrinol (Oxf). 2000 Feb;52(2):203-9. doi: 10.1046/j.1365-2265.2000.00900.x. Clin Endocrinol (Oxf). 2000. PMID: 10671948

2

Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism.

Fujiyama K, Kiriyama T, Ito M, Nakata K, Yamashita S, Yokoyama N, Nagataki S. Fujiyama K, et al. J Clin Endocrinol Metab. 1995 Jul;80(7):2135-8. doi: 10.1210/jcem.80.7.7608266. J Clin Endocrinol Metab. 1995. PMID: 7608266

3

[Biochemical markers of bone turnover for treatment of osteoporosis].

Fujiyama K, Kiriyama T. Fujiyama K, et al. Nihon Rinsho. 2002 Mar;60 Suppl 3:256-62. Nihon Rinsho. 2002. PMID: 11979917 Review. Japanese. No abstract available.

4

Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women.

Fujiyama K, Kiriyama T, Ito M, Kimura H, Ashizawa K, Tsuruta M, Nagayama Y, Villadolid MC, Yokoyama N, Nagataki S. Fujiyama K, et al. Thyroid. 1995 Feb;5(1):13-7. doi: 10.1089/thy.1995.5.13. Thyroid. 1995. PMID: 7787427

5

Inhibitory effect of glucocorticoid for osteoblast apoptosis induced by activated peripheral blood mononuclear cells.

Nakashima T, Sasaki H, Tsuboi M, Kawakami A, Fujiyama K, Kiriyama T, Eguchi K, Ichikawa M, Nagataki S. Nakashima T, et al. Among authors: fujiyama k. Endocrinology. 1998 Apr;139(4):2032-40. doi: 10.1210/endo.139.4.5932. Endocrinology. 1998. PMID: 9528991

6

[Bone changes in thyrotoxicosis].

Ejima E, Fujiyama K, Kiriyama T, Eguchi K. Ejima E, et al. Among authors: fujiyama k. Nihon Rinsho. 1998 Jun;56(6):1587-90. Nihon Rinsho. 1998. PMID: 9648486 Review. Japanese.

7

Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells.

Abe Y, Kawakami A, Nakashima T, Ejima E, Fujiyama K, Kiriyama T, Ide A, Sera N, Usa T, Tominaga T, Ashizawa K, Yokoyama N, Eguchi K. Abe Y, et al. Among authors: fujiyama k. J Lab Clin Med. 2000 Nov;136(5):344-54. doi: 10.1067/mlc.2000.109757. J Lab Clin Med. 2000. PMID: 11079461

8

Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts.

Tsuboi M, Kawakami A, Nakashima T, Matsuoka N, Urayama S, Kawabe Y, Fujiyama K, Kiriyama T, Aoyagi T, Maeda K, Eguchi K. Tsuboi M, et al. Among authors: fujiyama k. J Lab Clin Med. 1999 Sep;134(3):222-31. doi: 10.1016/s0022-2143(99)90201-9. J Lab Clin Med. 1999. PMID: 10482306

9

Cultured oncogenic osteomalacia tumor cells produce a factor(s) that inhibits osteocalcin production by osteoblastic cells.

Ejima E, Kiriyama T, Fujiyama K, Abe Y, Ashizawa K, Tominaga T, Sera N, Tamura M, Yokoyama N, Nagataki S. Ejima E, et al. Among authors: fujiyama k. Oncol Rep. 1997 Nov-Dec;4(6):1327-30. doi: 10.3892/or.4.6.1327. Oncol Rep. 1997. PMID: 21590247

10

Acquired nephrogenic diabetes insipidus secondary to distal renal tubular acidosis and nephrocalcinosis associated with Sjögren's syndrome.

Nagayama Y, Shigeno M, Nakagawa Y, Suganuma A, Takeshita A, Fujiyama K, Ashizawa K, Kiriyama T, Yokoyama N, Nagataki S. Nagayama Y, et al. Among authors: fujiyama k. J Endocrinol Invest. 1994 Sep;17(8):659-63. doi: 10.1007/BF03349682. J Endocrinol Invest. 1994. PMID: 7868806

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters